Nagano H - Search Results

1

CD13 is a therapeutic target in human liver cancer stem cells.

Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M. Haraguchi N, et al. Among authors: nagano h. J Clin Invest. 2010 Sep;120(9):3326-39. doi: 10.1172/JCI42550. Epub 2010 Aug 9. J Clin Invest. 2010. PMID: 20697159 Free PMC article.

2

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.

Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M. Yamamoto T, et al. Among authors: nagano h. Clin Cancer Res. 2004 Dec 1;10(23):7884-95. doi: 10.1158/1078-0432.CCR-04-0794. Clin Cancer Res. 2004. PMID: 15585621

3

Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M. Kondo M, et al. Among authors: nagano h. Clin Cancer Res. 2005 Feb 1;11(3):1277-86. Clin Cancer Res. 2005. PMID: 15709199

4

TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.

Damdinsuren B, Nagano H, Kondo M, Natsag J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M. Damdinsuren B, et al. Among authors: nagano h. Oncol Rep. 2006 Feb;15(2):401-8. Oncol Rep. 2006. PMID: 16391861

5

Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.

Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M. Nakamura M, et al. Among authors: nagano h. Hepatol Res. 2006 Aug;35(4):289-95. doi: 10.1016/j.hepres.2006.04.014. Epub 2006 Jun 12. Hepatol Res. 2006. PMID: 16769246

6

Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.

Ota H, Nagano H, Doki Y, Sekimoto M, Kondo M, Wada H, Nakamura M, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M. Ota H, et al. Among authors: nagano h. Oncol Rep. 2006 Aug;16(2):249-55. Oncol Rep. 2006. PMID: 16820899

7

[FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma].

Nagano H, Monden M. Nagano H, et al. Nihon Rinsho. 2006 Jul;64(7):1314-8. Nihon Rinsho. 2006. PMID: 16838650 Review. Japanese.

8

Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.

Tsujie M, Nakamori S, Nakahira S, Takeda S, Takahashi Y, Hayashi N, Okami J, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Tsujie M, et al. Among authors: nagano h. Pancreas. 2006 Aug;33(2):142-7. doi: 10.1097/01.mpa.0000226882.48204.26. Pancreas. 2006. PMID: 16868479

9

Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.

Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M. Nakamura M, et al. Among authors: nagano h. J Hepatol. 2007 Jan;46(1):77-88. doi: 10.1016/j.jhep.2006.07.032. Epub 2006 Sep 25. J Hepatol. 2007. PMID: 17045692

10

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.

Nakahira S, Nakamori S, Tsujie M, Takahashi Y, Okami J, Yoshioka S, Yamasaki M, Marubashi S, Takemasa I, Miyamoto A, Takeda Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Nakahira S, et al. Among authors: nagano h. Int J Cancer. 2007 Mar 15;120(6):1355-63. doi: 10.1002/ijc.22390. Int J Cancer. 2007. PMID: 17131328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,477 results

Search Page

Filters